Smith Graham & Co Investment Advisors’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-310,922
Closed -$7.04M 142
2016
Q3
$7.04M Buy
310,922
+37,920
+14% +$828K 0.9% 35
2016
Q2
$5.17M Buy
273,002
+15,300
+6% +$319K 0.71% 62
2016
Q1
$6.74M Buy
257,702
+9,140
+4% +$212K 0.88% 34
2015
Q4
$6.4M Sell
248,562
-7,220
-3% -$195K 0.91% 37
2015
Q3
$5.75M Sell
255,782
-660
-0.3% -$16.9K 0.84% 47
2015
Q2
$7.67M Sell
256,442
-2,700
-1% -$76.1K 1.03% 28
2015
Q1
$6.31M Buy
+259,142
New +$5.82M 0.85% 48

Other funds holding TBI

Smith Graham & Co Investment Advisors's TBI Position: Q4 2016 in Review

Smith Graham & Co Investment Advisors sold out of Trueblue (TBI) in Q4 2016, closing a stake of 310,922 shares — an estimated $7.04M sold.

Smith Graham & Co Investment Advisors first reported a position in TBI in Q1 2015 and held it in 7 quarters. The position peaked at $7.67M in Q2 2015. 182 funds tracked by Wall St. Rank hold TBI as of Q4 2016.

  • Smith Graham & Co Investment Advisors reported no remaining Trueblue position as of Q4 2016 after selling out during the quarter.
  • Smith Graham & Co Investment Advisors sold 310,922 Trueblue shares in Q4 2016, an estimated $7.04M.
  • Smith Graham & Co Investment Advisors first reported a position in Trueblue in Q1 2015 and held it in 7 quarters.
  • Smith Graham & Co Investment Advisors's Trueblue position peaked at $7.67M in Q2 2015.
  • 182 funds tracked by Wall St. Rank held Trueblue as of Q4 2016.

Based on Smith Graham & Co Investment Advisors's 13F filing for Q4 2016, filed 13 Jan 2017.